Lataa...
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma
Adrenocortical carcinoma (ACC) is a rare, highly aggressive cancer, often insensitive to conventional chemotherapeutics agents. Early diagnosis, followed by radical surgical resection plus/minus adjuvant mitotane therapy, is nowadays the only valuable option. Unfortunately, one out of four patients...
Tallennettuna:
| Julkaisussa: | J Oncol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463568/ https://ncbi.nlm.nih.gov/pubmed/31057613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6072863 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|